microgen
Information Management Solutions
www.microgen.co.uk
26th July 2006
Microgen plc (the "Company")
Notifiable Interests
The Company received notice on 26th July 2006 under Sections 198-202 of the
Companies Act 1985 that Aberforth Partners LLP is interested in 15,538,151
Ordinary Shares representing 15.14% of the issued share capital of the Company,
which is currently 102,641,214 Ordinary Shares.
The shares are registered in the name of:
No. of shares
Nortrust Nominees Limited A/C ABERFRTH 12,658,551
Bank of Ireland Nominees Limited 704,400
The Church Commissioners for England (Chase 1,016,300
GIS) Nominees Limited
State Street Nominees Limited A/C JD59 1,158,900
15,538,151
If you require further information please contact:
G.E. Liddle, Company Secretary
Tel: 01252 772 326
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.